Chen, A., Woyach, J. A., Seymour, J. F., Brander, D. M., Stephens, D. M., Kay, N. E., Tan, F., Chen, Y., Anthony, S. P., Shang, K., Shen, Y., Lou, Y., Byrd, J. C. (2026). ROCKET-CLL: A randomized, open-label, multicenter, phase 3 study of rocbrutinib (LP-168) versus pirtobrutinib in covalent BTK inhibitor (cBTKi) in pretreated relapsed or refractory (R/R) chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.tps7100